Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

SELL
$12.21 - $16.99 $9,157 - $12,742
-750 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$9.03 - $19.72 $6,772 - $14,790
750 New
750 $10,000
Q2 2019

Aug 01, 2019

SELL
$15.0 - $19.62 $60,000 - $78,480
-4,000 Closed
0 $0
Q1 2019

May 20, 2019

BUY
$11.65 - $17.72 $46,600 - $70,880
4,000 New
4,000 $69,000
Q4 2018

Feb 15, 2019

SELL
$10.72 - $16.73 $21,440 - $33,460
-2,000 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$17.73 - $26.69 $17,730 - $26,690
1,000 Added 100.0%
2,000 $49,000
Q2 2018

Jul 27, 2018

BUY
$10.79 - $24.44 $10,790 - $24,440
1,000 New
1,000 $22,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $712M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.